Specifically, in patients with T2DM, GLP-1 RAs prevent the occurrence of clinical events over time such as cardiovascular outcomes, diabetes complication, and all-cause mortality by improving glycemic control and by reducing body weight and insulin resistance [87,88]. Here, GLP1R is linked to type 2 diabetes mellitus.